Neo Ivy Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $794K | Buy |
+7,392
| New | +$794K | 0.25% | 139 |
|
|
2022
Q2 | – | Sell |
-2,498
| Closed | -$110K | – | 416 |
|
|
2022
Q1 | $110K | Buy |
2,498
+531
| +27% | +$23.4K | 0.1% | 293 |
|
|
2021
Q4 | $84K | Sell |
1,967
-11,574
| -85% | -$494K | 0.12% | 235 |
|
|
2021
Q3 | $475K | Buy |
13,541
+486
| +4% | +$17K | 0.54% | 57 |
|
|
2021
Q2 | $558K | Buy |
13,055
+8,321
| +176% | +$356K | 0.56% | 48 |
|
|
2021
Q1 | $183K | Buy |
+4,734
| New | +$183K | 0.2% | 169 |
|
|
2020
Q4 | – | Sell |
-17,085
| Closed | -$652K | – | 427 |
|
|
2020
Q3 | $652K | Buy |
17,085
+3,544
| +26% | +$135K | 0.66% | 27 |
|
|
2020
Q2 | $475K | Buy |
13,541
+8,081
| +148% | +$283K | 0.54% | 57 |
|
|
2020
Q1 | $178K | Buy |
+5,460
| New | +$178K | 0.29% | 134 |
|
|
2019
Q4 | – | Sell |
-525
| Closed | -$22K | – | 273 |
|
|
2019
Q3 | $22K | Buy |
+525
| New | +$22K | 0.01% | 255 |
|